mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.65 |
0.01 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |